Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma

ObjectiveHepatocellular carcinoma (HCC) is one of the most common and malignant tumors with an insidious onset, difficult early diagnosis, and limited therapy options, resulting in a poor prognosis. Cell division cycle associated 2 (CDCA2), also known as Repo-Man, plays an important role in regulati...

Full description

Bibliographic Details
Main Authors: Zhenjun Yu, Yu Zhang, Shuai Shao, Qi Liu, Yuhan Li, Xiaoxiao Du, Kun Zhang, Mengxia Zhang, Haixia Yuan, Qiang Yuan, Tong Liu, Yingtang Gao, Yijun Wang, Wei Hong, Tao Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Oncology
Subjects:
CDCA2
hepatocellular carcinoma
biomarker
prognosis
bioinformatics
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.755814/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.755814/full

Similar Items